Prelude Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,691
| Closed | -$635K | – | 2115 |
|
|
2021
Q3 | $635K | Buy |
+3,691
| New | +$635K | 0.02% | 568 |
|
|
2020
Q3 | – | Sell |
-1,696
| Closed | -$162K | – | 2037 |
|
|
2020
Q2 | $162K | Buy |
+1,696
| New | +$162K | 0.01% | 540 |
|
|
2020
Q1 | – | Sell |
-156
| Closed | -$8K | – | 1767 |
|
|
2019
Q4 | $8K | Buy |
156
+97
| +164% | +$4.97K | ﹤0.01% | 1263 |
|
|
2019
Q3 | $2K | Sell |
59
-2
| -3% | -$68 | ﹤0.01% | 1119 |
|
|
2019
Q2 | $3K | Sell |
61
-3,048
| -98% | -$150K | ﹤0.01% | 1158 |
|
|
2019
Q1 | $145K | Buy |
+3,109
| New | +$145K | 0.01% | 528 |
|
|
2018
Q4 | – | Sell |
-22,263
| Closed | -$1.27M | – | 1870 |
|
|
2018
Q3 | $1.27M | Buy |
22,263
+10,826
| +95% | +$620K | 0.07% | 191 |
|
|
2018
Q2 | $555K | Buy |
+11,437
| New | +$555K | 0.04% | 390 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 2059 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 2168 |
|
|
2014
Q3 | – | Sell |
-500
| Closed | -$17K | – | 2082 |
|
|
2014
Q2 | $17K | Buy |
+500
| New | +$17K | ﹤0.01% | 1591 |
|